Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era

Prostate

Volumn 68, Issue 14, 2008, Pages 1582-1591

  Chen, Yen Ching ^a,b   Page, John H ^c   Chen, Rong ^a   Giovannucci, Edward ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast cancer; Family history; Prostate cancer; PSA era

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FATHER; HUMAN; MALE; MASS SCREENING; MOTHER; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SIBLING; ADENOCARCINOMA; AGED; BLOOD; BREAST TUMOR; COHORT ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RISK; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK; UNITED STATES;

EID: 51649101380     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20825     Document Type: Article

References (44)

1. Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, Willett WC. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 2003;95(16):1240-1244.
2. Rohrmann S, Roberts WW, Walsh PC, Platz EA. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 2003;55(2):140-146.
3. Amling CL. Relationship between obesity and prostate cancer. Curr Opin Urol 2005;15(3):167-171.
4. Chan JM, Stampfer MJ, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 1998;8(4):263-273.
5. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, Giovannucci E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90(16):1219-1224.
6. Thiessen EU. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer 1974;34:1102-1107.
7. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surveys 1982;1:47-69.
8. Rodriguez C, Calle EE, Tatham LM, Wingo PA, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Family history of breast cancer as a predictor for fatal prostate cancer. Epidemiology 1998;9(5):525-529.
9. Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999;8(1):53-60.
10. Makinen T, Tammela TL, Stenman UH, Maattanen L, Rannikko S, Aro J, Juusela H, Hakama M, Auvinen A. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol 2002;20(11):2658-2663.
11. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343(2):78-85.
12. Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996;144(11):1041-1047.
13. Rodriguez C, Calle EE, Miracle-McMahill HL, Tatham LM, Wingo PA, Thun MJ, Heath CW Jr. Family history and risk of fatal prostate cancer. Epidemiology 1997;8(6):653-657.
14. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis. Int J Cancer 2003;107(5):797-803.
15. Matikainen MP, Schleutker J, Morsky P, Kallioniemi OP, Tammela TL. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families. Clin Cancer Res 1999;5(6):1275-1279.
16. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141(8):732-740.
17. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17(4):337-347.
18. Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 2002;50(4):216-221.
19. Catalona WJ, Antenor JA, Roehl KA, Moul JW. Screening for prostate cancer in high risk populations. J Urol 2002;168(5):1980-1983 discussion 1983-1984.
20. Merrill RM, Hilton SC, Wiggins CL, Sturgeon JD. Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah. BMC Cancer 2003;3(1):14.
21. Lyon JL, Klauber MR, Gardner JW, Smart CR. Cancer incidence in Mormons and non-Mormons in Utah, 1966-1970. N Engl J Med 1976;294(3):129-133.
22. Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 2004;13(2):80-85.
23. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol 1984;119:837-839.
24. Sutcliffe S, Giovannucci E, Leitzmann MF, Rimm EB, Stampfer MJ, Willett WC, Platz EA. A prospective cohort study of red wine consumption and risk of prostate cancer. Int J Cancer 2007;120(7):1529-1535.
25. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91(9):789-794.
26. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739-744.
27. Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1998;57:326-331.
28. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Silverman DT, Brown LM, Hoover RN, Fraumeni, JF, Jr. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995;60(3):361-364.
29. Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO. Lifestyle factors and prostate cancer risk: A case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 1996;5(7):509-513.
30. Narod SA, Dupont A, Cusan L, Diamond P, Gomez JL, Suburu R, Labrie F. The impact of family history on early detection of prostate cancer. Nat Med 1995;1(2):99-101.
31. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: A case-control analysis. J Urol 1991;146(5):1305-1307.
32. Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostatic cancer: A case-control study. Prostate 1990;17(3):189-206.
33. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13(5):471-482.
34. Rauh-Adelmann C, Lau KM, Sabeti N, Long JP, Mok SC, Ho SM. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines. Mol Carcinog 2000;28(4):236-246.
35. Rosen EM, Fan S, Goldberg ID. BRCA1 and prostate cancer. Cancer Invest 2001;19(4):396-412.
36. Norrish AE, McRae CU, Cohen RJ, Jackson RT. A population-based study of clinical and pathological prognostic characteristics of men with familial and sporadic prostate cancer. BJU Int 1999;84(3):311-315.
37. Klein EA, Kupelian PA, Witte JS. Does a family history of prostate cancer result in more aggressive disease? Prostate Cancer Prostatic Dis 1998;1(6):297-300.
38. Gronberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, Xu J, Meyers DA, Collins FS, Trent JM, Walsh PC, Isaacs WB. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997;278(15):1251-1255.
39. Kotsis SV, Spencer SL, Peyser PA, Montie JE, Cooney KA. Early onset prostate cancer: Predictors of clinical grade. J Urol 2002;167(4):1659-1663.
40. Negri E, Pelucchi C, Talamini R, Montella M, Gallus S, Bosetti C, Franceschi S, La Vecchia C. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer 2005;114(4):648-652.
41. Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med 2001;24(3):247-258.
42. King TM, Tong L, Pack RJ, Spencer C, Amos CI. Accuracy of family history of cancer as reported by men with prostate cancer. Urology 2002;59(4):546-550.
43. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A. population-based case-control study. Eur J Cancer 1999;35(2):272-277.
44. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38(6):652-658.